Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 11, 2004, Pages 4106-4112

  Han, Ying ^a,b   Schneck, Marilyn E ^a   Bearse Jr , Marcus A ^a   Barez, Shirin ^a   Jacobsen, Carl H ^a   Jewell, Nicholas P ^a   Adams, Anthony J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL MODEL; TISSUE DISTRIBUTION;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PHOTOGRAPHY; PROBABILITY; RISK FACTORS; TIME FACTORS;

EID: 6944235851     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0405     Document Type: Article

References (37)

1. Diabetes Research Working Group. Conquering Diabetes: A Strategic Plan For the 21st Century. Bethesda, MD: National Institutes of Health; 1999. Publication no. 99-4398.
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342: 381-389.
3. Bailey CC, Sparrow JM, Grey RH, Cheng H. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye. 1999;13:151-159.
4. Liu QZ, Pettitt DJ, Hanson RL, et al. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia. 1993;36:428-432.
5. Donaghue KC, Fairchild JM, Craig ME, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care. 2003;26:1224-1229.
6. Wirta O, Pasternack A, Mustonen J, Laippala P, Lande Y. Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol. 1999;51:329-334.
7. Nguyen HT, Luzio SD, Dolben J, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications. 1996;10:211-219.
8. Aspinall PA, Kinnear PR, Duncan LJ, Clarke BF. Prediction of diabetic retinopathy from clinical variables and color vision data. Diabetes Care. 1983;6:144-148.
9. Bresnick GH, Korth K, Groo A, Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy: preliminary report. Arch Ophthalmol. 1984;102:1307-1311.
10. Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh). 1980;58:865-878.
11. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242-260.
12. Frank RN. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol. 2002; 133:693-698.
13. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Nakamura M. New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabetes Technol Ther. 2000;2:601-608.
14. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:948-954.
15. Sutler EE, Tran D. The field topography of ERG components in man: I. the photopic luminance response. Vision Res. 1992;32: 433-446.
16. Bearse MA Jr, Sutler EE. Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A. 1996;13:634-640.
17. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000;19:607-646.
18. Palmowski AM, Sutler EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1997;38:2586-2596.
19. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2638-2651.
20. Greenstein VC, Chen H, Hood DC, Holopigian K, Seiple W, Carr RE. Retinal function in diabetic macular edema after focal laser photocoagulation. Invest Ophthalmol Vis Sci. 2000;41:3655-3664.
21. Greenstein VC, Holopigian K, Hood DC, Seiple W, Carr RE. The nature and extent of retinal dysfunction associated with diabetic macular edema. Invest Ophthalmol Vis Sci. 2000;41:3643-3654.
22. Shimada Y, Li Y, Bearse MA Jr, Sutter EE, Fung W. Assessment of early retinal changes in diabetes using a new multifocal ERG protocol. Br J Ophthalmol. 2001;85:414-419.
23. Bearse MA Jr, Han Y, Schneck ME, Adams AJ. Retinal function in normal and diabetic eyes mapped with the slow flash multifocal electroretinogram (sf-mfERG). Invest Ophthalmol Vis Sci. 2004; 45:296-304.
24. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Towards optimal filtering of "standard" multifocal electroretinogram (mfERG) recordings: findings in normal and diabetic subjects. Br J Ophthalmol. 2004;88:543-550.
25. Kurtenbach A, Langrova H, Zrenner E. Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci. 2000;41:3234-3241.
26. Kohner EM, MP. A Field Guide Book. Mannheim, Germany: Boehringer Mannheim; 1992.
27. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia. 1995;38:437-444.
28. Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000;23:345-348.
29. Hood DC, Li J. A technique for measuring individual multifocal ERG records In: Yager D, ed. Trends in Optics and Photonics. Washington, DC: Optical Society of America; 1997;33-41.
30. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44: 1049-1060.
31. Jewell NP. Goodness of fit tests for logistic regression models and model building. In: Jewell NP, ed. Statistics for Epidemiology. Boca Raton, FL: CRC Press; 2003;246-250.
32. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
33. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154:2169-2178.
34. Yanko L, Goldbourt U, Michaelson IC, Shapiro A, Yaari S. Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol. 1983;67:759-765.
35. Diabetes Control and Complications Trial Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47:1703-1720.
36. Hood DC, Frishman LJ, Saszik S, Viswanathan S. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci. 2002;43:1673-1685.
37. Hare WA, Ton H. Effects of APB, PDA, and TTX on ERG responses recorded using both multifocal and conventional methods in monkey: effects of APB, PDA, and TTX on monkey ERG responses. Doc Ophthalmol. 2002;105:189-222.